PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.\', \'Department of Pharmacology and Toxicology, College of Pharmacy, Hawler Medical University, Kurdistan Region Government, Erbil, Iraq.\', \'Division of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden.\', \'Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/prp2.666
?:doi
?:hasPublicationType
?:journal
  • Pharmacology research & perspectives
is ?:pmid of
?:pmid
?:pmid
  • 33084232
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all